Outcome of Board meeting for Appointment Statutory Auditor and Independent Director .
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bacil Pharma Ltd's Board of Directors met on 25th August 2025 and approved two key appointments. First, M/s Sarang Shivajirao Chavan & Associate was appointed as the company's Statutory Auditor. Second, Mr. Vivek Mukesh Yadav (DIN: 10778075) was appointed as an Independent Director of the company, effective 25th August 2025. Mr. Yadav brings experience in finance, accounts, and corporate management, and is not debarred from holding directorship by SEBI or any other authority. The board meeting ran from 5:00 PM to 6:15 PM.
These are routine governance appointments — a new statutory auditor and an additional independent director — which should strengthen the company's compliance and oversight structure. No negative signals such as resignations or governance flags were disclosed in this filing.